6580.Two
6580.TWO operates in the healthcare diagnostics segment, providing products and services related to medical testing and diagnostic solutions.
Business. 6580.TWO operates in the healthcare diagnostics segment, providing products and services related to medical testing and diagnostic solutions.
At a glance
What drives this business
The watch-list the newsroom runs for this company — derived from its sector path, sharpened layer by layer. Not investment advice.
News & coverage
0Sector rotation
Developing storylines
Analysis
AI analysisOpportunity
Upcoming catalysts
Scheduled public events. Informational only — not investment advice.
- Macro
- Rate decisionBank of England rate decision (press conf.)2026-08-06 · GB
- Rate decisionReserve Bank of Australia rate decision (press conf.)2026-08-12 · AU
- Rate decisionNorges Bank rate decision (press conf.)2026-08-20 · NO
- Rate decisionSveriges Riksbank rate decision (press conf.)2026-09-03 · SE
- Rate decisionBank of Canada rate decision (press conf.)2026-09-09 · CA
- Rate decisionEuropean Central Bank rate decision (press conf.)2026-09-10 · EU
- Macro & political
- ElectionSE Swedish Election2026-09-14 · SE
- ElectionUS U.S. Midterms2026-11-03 · US
- ElectionFR French Legislative2027-06-01 · FR
Pre-earnings brief
Signals & dispatch
Composite-score breakdown
Synthesis
6580.TWO operates in the healthcare diagnostics segment, providing products and services related to medical testing and diagnostic solutions.
The company's capital structure is characterized by a high level of equity, with total equity of 441,592,000 TWD and total liabilities of 23,644,000 TWD, resulting in a debt-to-equity ratio of 0.01. The company maintains a strong liquidity position, with cash and equivalents amounting to 90,000,000 TWD and a current ratio of 18.53. However, the company is experiencing negative operating and free cash flows, with operating cash flow of -178,474,000 TWD and free cash flow of -215,653,000 TWD.
Profitability metrics indicate significant underperformance, with a return on equity of -0.5008 and a return on assets of -0.4753. These figures are well below the industry median for return on equity and return on assets, suggesting that the company is not generating returns at a level typical for its industry.
The company's revenue is concentrated in a single segment, as disclosed in its financial statements, with no additional geographic or segment breakdown provided in the available data. This lack of diversification may expose the company to higher risk if demand in its primary market fluctuates.
The company's growth trajectory is currently negative, with a net loss of 221,128,000 TWD and an operating loss of 237,356,000 TWD. There are no immediate filing-based liquidity or dilution flags, and the risk assessment indicates low liquidity and dilution risk.
Recent events and filings do not indicate any significant changes in the company's financial or operational status. The company has not issued any new shares or taken on additional debt in the latest reporting period.
- The company has a strong liquidity position with a current ratio of 18.53 and significant cash reserves.
- The company is experiencing significant losses, with a net loss of 221,128,000 TWD and an operating loss of 237,356,000 TWD.
- The company's capital structure is heavily equity-based, with a debt-to-equity ratio of 0.01.
- The company's profitability metrics are below industry medians, indicating underperformance.
- The company has no immediate liquidity or dilution risks, but its negative cash flows may impact future operations.
Bull / Bear case
analysis pipelineIn focus — financials by report
Valuation
Revenue by segment
Business relationships
Supply chain
Peer comparison
Market position
Stress test
Predictor forecast
Options
Short squeeze
Earnings-call key lines
Estimate revisions
consensus EPS · 26-week trendSell-side observations
Themes
ESG
Risk factors
- No immediate filing-based liquidity or dilution flags were detected.
Benchmarks vs cohort
Corporate actions / M&A
FX exposure
Comparable transactions
Derivatives & instruments
Actions
Ask Handelsavisen
- Market data
- Market data cache
- Issuer disclosures
- Public news
- Earnings transcripts
- Consensus estimates
- ESG data
- Dilution Ratio(shares_outstanding_diluted - shares_outstanding_basic) / shares_outstanding_basic
- Net Cashcash_and_equivalents + short_term_investments - short_term_debt - long_term_debt
- Capex To Revenuecapital_expenditure / revenue
- Return On Equitynet_income / total_equity
- Debt To Equity(short_term_debt + long_term_debt) / total_equity
- Cash Conversion Ratiooperating_cash_flow / net_income
- 6580.TWO Market data — financials · 2026-05-27